(0.91%) 5 064.20 points
(0.85%) 38 226 points
(1.51%) 15 841 points
(0.24%) $79.14
(-0.93%) $2.02
(0.00%) $2 309.50
(0.15%) $26.87
(0.28%) $965.30
(-0.07%) $0.932
(-0.10%) $10.98
(-0.14%) $0.797
(1.51%) $92.51
3.30% $ 33.85
Live Chart Being Loaded With Signals
Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally...
Stats | |
---|---|
Объем за сегодня | 56 591.00 |
Средний объем | 269 942 |
Рыночная капитализация | 0.00 |
EPS | $0 ( 2022-08-02 ) |
Last Dividend | $0.191 ( 2022-08-11 ) |
Next Dividend | $0 ( N/A ) |
P/E | 0 |
ATR14 | $1.073 (3.17%) |
Объем Корреляция
Koninklijke DSM N.V. Корреляция
10 Самые положительные корреляции |
---|
10 Самые отрицательные корреляции |
---|
Вы знали?
Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).
Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.
Koninklijke DSM N.V. Корреляция - Валюта/Сырье
Koninklijke DSM N.V. Финансовые показатели
Annual | 2021 |
Выручка: | $9.20B |
Валовая прибыль: | $3.16B (34.38 %) |
EPS: | $2.44 |
FY | 2021 |
Выручка: | $9.20B |
Валовая прибыль: | $3.16B (34.38 %) |
EPS: | $2.44 |
FY | 2020 |
Выручка: | $8.11B |
Валовая прибыль: | $2.78B (34.25 %) |
EPS: | $0.728 |
FY | 2019 |
Выручка: | $9.01B |
Валовая прибыль: | $3.05B (33.88 %) |
EPS: | $1.068 |
Financial Reports:
No articles found.
Koninklijke DSM N.V. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.191 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0635 | 2001-07-31 |
Last Dividend | $0.191 | 2022-08-11 |
Next Dividend | $0 | N/A |
Payout Date | 2022-09-02 | |
Next Payout Date | N/A | |
# dividends | 42 | -- |
Total Paid Out | $10.48 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.74 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 3.53 | |
Div. Directional Score | 7.75 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
TRCY | Ex Dividend Knight | 2023-07-28 | Quarterly | 0 | 0.00% | |
IMBBY | Ex Dividend Knight | 2023-08-17 | Quarterly | 0 | 0.00% | |
BDULF | Ex Dividend Knight | 2023-09-12 | Annually | 0 | 0.00% | |
PUBGY | Ex Dividend Knight | 2023-06-30 | Annually | 0 | 0.00% | |
EMSHF | Ex Dividend Knight | 2023-08-15 | Annually | 0 | 0.00% | |
VIAAY | Ex Dividend Junior | 2023-06-12 | Sporadic | 0 | 0.00% | |
KNRRY | Ex Dividend Knight | 2023-05-08 | Annually | 0 | 0.00% | |
CBCFF | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
SCBFY | Ex Dividend Junior | 2023-08-10 | Semi-Annually | 0 | 0.00% | |
FOTB | Ex Dividend Junior | 2023-05-31 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0812 | 1.500 | 8.38 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0466 | 1.200 | 8.45 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0894 | 1.500 | -0.118 | -0.177 | [0.1 - 1] |
payoutRatioTTM | 0.356 | -1.000 | 6.44 | -6.44 | [0 - 1] |
currentRatioTTM | 2.52 | 0.800 | 2.39 | 1.915 | [1 - 3] |
quickRatioTTM | 0.843 | 0.800 | 9.75 | 7.80 | [0.8 - 2.5] |
cashRatioTTM | 0.642 | 1.500 | 7.54 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.193 | -1.500 | 6.78 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 17.76 | 1.000 | 4.53 | 4.53 | [3 - 30] |
operatingCashFlowPerShareTTM | 2.08 | 2.00 | 9.31 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.239 | 2.00 | 9.38 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.332 | -1.500 | 8.67 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.344 | 1.000 | 7.60 | 7.60 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.212 | 1.000 | 7.75 | 7.75 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.461 | 1.000 | 8.55 | 8.55 | [0.2 - 2] |
assetTurnoverTTM | 0.575 | 0.800 | 9.50 | 7.60 | [0.5 - 2] |
Total Score | 11.97 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 29.01 | 1.000 | 7.17 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0894 | 2.50 | -0.0759 | -0.177 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.239 | 2.00 | 9.59 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 2.08 | 2.00 | 9.31 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.356 | 1.500 | 6.44 | -6.44 | [0 - 1] |
pegRatioTTM | -0.816 | 1.500 | -8.77 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.155 | 1.000 | 8.62 | 0 | [0.1 - 0.5] |
Total Score | 3.53 |
Koninklijke DSM N.V.
Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, premixes, carotenoids, enzymes, microbes, and eubiotics; human nutrition and health products comprising vitamins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics, and prebiotics, as well as active pharmaceutical ingredients; premix, market-ready solutions, and personalized nutrition; human milk oligosaccharides; and skin and sun care, hair care, and aroma ingredients; omega-3 fatty acids; and specialty food enzymes, cultures, bio-preservation, texturizing hydrocolloids, sugar reduction, and savory taste solutions. The Materials segment provides specialty plastics used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries; and Dyneema, a fiber solution for use in personal protection, workwear, sports apparel, outdoor equipment, ropes and slings, synthetic chains, and nets for the aquaculture, and renewable energy sectors. The Innovation Center segment offers biomedical materials, and medical device and material manufacturing technologies in the areas of cardiovascular, continence care, dental, diabetes management, gynecology, neurology, ophthalmology, orthopedic, peripheral vascular, plastic and reconstructive surgery, and wound management. It also commercializes yeast technology yeast for ethanol production. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands.
О Торговые сигналы
Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.
Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа